Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
Tushar Saha, Miguel E. Quiñones‐Mateu, Shyamal C. Das
International Journal of Pharmaceutics (2022) Vol. 624, pp. 122042-122042
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives
Siyuan Peng, Wenhao Wang, Rui Zhang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 161-161
Open Access | Times Cited: 17
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Hezhi Wang, Qin Lu, Xin Zhang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 970-993
Open Access | Times Cited: 48
Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers
Dominika Žigrayová, Veronika Mikušová, Peter Mikuš
Viruses (2023) Vol. 15, Iss. 3, pp. 647-647
Open Access | Times Cited: 23
Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitro
Catherine K. Su, Tushar Saha, Shubhra Sinha, et al.
International Journal of Pharmaceutics (2025), pp. 125302-125302
Closed Access | Times Cited: 1
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery
Thiago Medeiros Zacaron, Mariana Leite Simões e Silva, Mirsiane Pascoal Costa, et al.
Polymers (2023) Vol. 15, Iss. 18, pp. 3849-3849
Open Access | Times Cited: 22
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Closed Access | Times Cited: 19
Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
Junwei Gao, Can Cao, Mingfei Shi, et al.
Phytomedicine (2023) Vol. 118, pp. 154942-154942
Open Access | Times Cited: 17
Development of favipiravir loaded PLGA nanoparticles entrapped in in-situ gel for treatment of Covid-19 via nasal route
Vaishnavi Gattani, Shilpa Dawre
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104082-104082
Open Access | Times Cited: 26
Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery
Min-Seok Yang, Ji–Hyun Kang, Dong‐Wook Kim, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 54, Iss. 2, pp. 113-130
Closed Access | Times Cited: 12
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
Tushar Saha, Zia Uddin Masum, Anik Naha Biswas, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 252-252
Open Access
Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia
Tom Bourguignon, Jesus Alfredo Godinez-Leon, Amine Pochet, et al.
International Journal of Pharmaceutics (2025) Vol. 677, pp. 125634-125634
Open Access
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation
Seyedeh Negin Kassaee, Derek J. Richard, Godwin A. Ayoko, et al.
Nanomedicine (2024) Vol. 19, Iss. 25, pp. 2113-2133
Closed Access | Times Cited: 3
Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
International Journal of Pharmaceutics (2023) Vol. 645, pp. 123411-123411
Open Access | Times Cited: 9
Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections
Michael Y.T. Chow, Harry W. Pan, Han Cong Seow, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 2, pp. 85-97
Open Access | Times Cited: 14
COVID‐19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples
Chukwunonso K. Nwabufo, Jessica G.Y. Luc, Allison McGeer, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 9, pp. 2137-2158
Open Access | Times Cited: 2
Sucrose versus Trehalose: Observations from Comparative Study Using Molecular Dynamics Simulations
Inna Ermilova, Alexander P. Lyubartsev, Vitaly Kocherbitov
ACS Omega (2024) Vol. 9, Iss. 46, pp. 46323-46338
Open Access | Times Cited: 2
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2229-2229
Open Access | Times Cited: 6
The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe Hydroxychloroquine Inhalation Aerogel
Mo’tasem M. Alsmadi, Mays M. Jaradat, Rana Obaidat, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 4
Fascism in Medicine and Everyday Life
Sergei V. Jargin
Authorea (Authorea) (2024)
Open Access | Times Cited: 1
A perspective current and past modes of inhalation therapy
J Canto Mangana, Kelsey Aguirre Schilder, José Ignacio Bretones‐Pedrinaci, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 1
Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19)
Nur Dini Fatini Mohammad Faizal, Mohd Cairul Iqbal Mohd Amin
International Journal of Pharmaceutics (2022) Vol. 630, pp. 122421-122421
Open Access | Times Cited: 6
An engineered ACE2 decoy broadly neutralizes Omicron subvariants and shows therapeutic effect in SARS-CoV-2-infected cynomolgus macaques
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
In silico identification of five binding sites on the SARS-CoV-2 spike protein and selection of seven ligands for such sites
Denilson F. Oliveira
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-19
Closed Access | Times Cited: 1
Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections
Tushar Saha, Nikita Lyons, Deborah Bow Yue Yung, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 195, pp. 114170-114170
Open Access | Times Cited: 1
Antiviral activity of aminocaproic acid against SARS-CoV-2: review of the literature and results of the first experimental study
Jeanne Chiaravalli, A. Verneuil, V. Osiichuk, et al.
Infusion & Chemotherapy (2022), Iss. 3, pp. 5-12
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top